Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II …
Biotechnology
US, Lexington [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Cyteir Therapeutics, Inc. (CYT) to it's peer group.
Peer Group
GRPH RZLT FHTX MGTA LYEL CSBR SANA ELYM CCCC GBIO NLTX NKTX HCWB GLUE ANEB MNOV PRLD NUVB
Compare Together
Loading...